Thu, February 3, 2011
Wed, February 2, 2011
Tue, February 1, 2011
Mon, January 31, 2011
Sun, January 30, 2011
Fri, January 28, 2011
Thu, January 27, 2011
Wed, January 26, 2011
Tue, January 25, 2011
Mon, January 24, 2011
Sun, January 23, 2011
Sat, January 22, 2011
Fri, January 21, 2011
Thu, January 20, 2011
Wed, January 19, 2011
Tue, January 18, 2011
Mon, January 17, 2011
Fri, January 14, 2011
[ Fri, Jan 14th 2011 ]: Market Wire
ICON Acquires Oxford Outcomes
Thu, January 13, 2011
Wed, January 12, 2011
Tue, January 11, 2011
Mon, January 10, 2011
[ Mon, Jan 10th 2011 ]: Market Wire
30 A.M. ET
Sun, January 9, 2011
Fri, January 7, 2011
Thu, January 6, 2011

The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Genopt


//health-fitness.news-articles.net/content/2011/ .. es-of-fiduciary-duty-by-the-board-of-genopt.html
Published in Health and Fitness on by Market Wire   Print publication without navigation



NEW YORK--([ BUSINESS WIRE ])--Levi & Korsinsky is investigating the Board of Directors of Genoptix, Inc. (aGenoptixa or the aCompanya) (Nasdaq: GXDX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Novartis. Under the terms of the transaction, Genoptix shareholders will receive $25.00 cash for each share of Genoptix common stock they own, for a total transaction value of approximately $470 million.

Click here to learn how to join the action: [ http://www.zlk.com/genoptix-gxdx.html ], or call: 877-363-5972.

The investigation concerns whether the Genoptix Board of Directors breached their fiduciary duties to Genoptix stockholders by failing to adequately shop the Company before entering into this transaction and whether Novartis is underpaying for Genoptix shares, thus unlawfully harming Genoptix stockholders. In particular, at least one analyst set a price target of $28.00 per share and Genoptix stock traded as high as $38.79 per share as recently as April 30, 2010.

If you own common stock in Genoptix and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at [ jlevi@zlk.com ] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit [ http://www.zlk.com/genoptix-gxdx.html ].

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.


Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear